Top

Clinical Research in Cardiology

Published in:

Open Access 01-02-2013 | Letter to the Editors

Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump

Authors: Marco R. Schroeter, Bernhard Unsöld, Karin Holke, Wolfgang Schillinger

Published in: Clinical Research in Cardiology | Issue 2/2013

Excerpt

Sirs: …

Sliwa K, Fett J, Elkayam U (2006) Peripartum cardiomypathy. Lancet 368:687–693PubMedCrossRef

Habli M, O’Brien T, Nowack E, Khoury S, Barton JR, Sibai B (2008) Peripartum cardiomyopathy: prognostic factors for long-term maternal outcome. Am J Obstet Gynecol 199(415):e411–e415

Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al (2011) ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 32:3147–3197PubMedCrossRef

Sliwa K, Hilfiker-Kleiner D, Petrie MC et al (2010) Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 12:767–778PubMedCrossRef

Böhm M, Voors AA, Ketelslegers JM, Schirmer SH, Turgonyi E, Bramlage P, Zannad F (2011) Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol 100:973–981PubMedCrossRef

Rademacher W, Lauten A, Lauten A, Ragoschke-Schumm A, Figulla HR (2010) Postpartum unmasking of a severe triple-vessel-disease with acute myocardial infarction. Clin Res Cardiol 99:701–706CrossRef

Sliwa K, Blauwet L, Tibazarwa K, Libhaber E, Smedema JP, Becker A, McMurray J, Yamac H, Labidi S, Struman I, Hilfiker-Kleiner D (2010) Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121:1465–1473PubMedCrossRef

Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114:409–414PubMedCrossRef

Siegenthaler MP, Brehm K, Strecker T, Hanke T, Nötzold A, Olscheeski M, Weyand M, Sievers H, Beyersdorf F (2004) The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three- center experience. J Thorac Cardiovasc Surg 127:812–822PubMedCrossRef

10.

Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R (2004) Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg 77:1642–1647PubMedCrossRef

Title: Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump
Authors: Marco R. Schroeter
Bernhard Unsöld
Karin Holke
Wolfgang Schillinger
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Clinical Research in Cardiology / Issue 2/2013
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-012-0494-5

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pro-thrombotic condition in a woman with peripartum cardiomyopathy treated with bromocriptine and an Impella LP 2.5 heart pump

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Baseline vectorcardiography as a predictor of invasively determined acute hemodynamic response to cardiac resynchronization therapy

Kounis syndrome due to angiotensin converting enzyme inhibitor

Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour

The groin first approach for transcatheter aortic valve implantation: are we pushing the limits for transapical implantation?

Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus

Percutaneous implantation of the Edwards SAPIEN™ pulmonic valve: initial results in the first 22 patients

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page